Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Talatisamine (12 μM) and TEA (5mM) inhibits the enhanced I(K) caused by Aβ4 oligomers, attenuates cytotoxicity of Aβ oligomers by restoring cell viability and suppressing K(+) loss related apoptotic response. 2. Talatisamine can therefore be considered as a leading compound worthy of further investigations.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 59.00 | |
5 mg | In stock | $ 129.00 | |
10 mg | In stock | $ 219.00 | |
25 mg | In stock | $ 385.00 | |
50 mg | In stock | $ 553.00 | |
100 mg | In stock | $ 835.00 |
Description | 1. Talatisamine (12 μM) and TEA (5mM) inhibits the enhanced I(K) caused by Aβ4 oligomers, attenuates cytotoxicity of Aβ oligomers by restoring cell viability and suppressing K(+) loss related apoptotic response. 2. Talatisamine can therefore be considered as a leading compound worthy of further investigations. |
Targets&IC50 | IK channel:146 μM |
Source |
Molecular Weight | 421.57 |
Formula | C24H39NO5 |
CAS No. | 20501-56-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32 mg/mL(75.9 mM)
Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Talatisamine 20501-56-8 Membrane transporter/Ion channel Potassium Channel KcsA Inhibitor Alzheimer's neurotoxicity inhibit disease inhibitor